старший научный сотрудник
кандидат медицинских наук
Centro Cardiologico Monzino IRCCS
Researcher
Laboratory of Cardiac Biochemistry
Aortic, Valvular and Coronary Pathologies Unit
Via Privata Carlo Parea 4
Milano, MI 20138
Phone (Office): +39 0258002748
Phone (Mobile): +39 33205665249
E-mail:
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Date and Place of Birth: October 16 th 1981, Moscow, Russia
Citizenship: Russian/Italian
2014 Degree in Medicine and Surgery. State University of Milan, Italy
2006 – 2010: Doctorate in Neurology and Pathophysiology. Institute of General Pathology and
Pathophysiology, Moscow, Russia.
2004-2006: Graduate School. Resident in Neurology. Institute of General Pathology and
Pathophysiology, Moscow, Russia.
1998-2004: Degree in Medicine. Moscow Institute of Medical and Social Rehabilitation, Moscow,
Russia
2016 – present: Researcher, Laboratory of Cardiac Biochemistry, Aortic, Valvular and Coronary
Pathologies Unit, Centro Cardiologico Monzino IRRCS, Milan, Italy.
2011-2015: Researcher, Laboratory of Cardiac Biochemistry, Unit of Atherosclerosis Prevention,
Centro Cardiologico Monzino IRCCS, Milan, Italy.
2008-2009: Research scientist in the “Heinz Nixdorf Recall Study”, Universitatsklinikum Essen,
Germany.
2004-2011: Researcher, Institute for Atherosclerosis Research, Moscow, Russia.
2006-2010 PhD in Neurology and Pathophysiology 24.02.2011. “Gender differences in the
development of subclinical atherosclerosis in patients with early signs of
cerebrovascular insufficiency.”
2006 I have obtain the certificate for performing ultrasound examination and monitoring of
carotid atherosclerosis for the international IMPROVE Study.
2007-2009 I have participated in two double-blinded placebo-controlled trials on atherosclerosis
regression.
2007-2009 PI in clinical trial “Antiatherosclerotic efficacy of Karinat in postmenopausal women”
2009-2010 I was a coordinator in Russian research group of multicenter study: “Mechanisms of
accelerated atherosclerosis in HIV-infected patient”.
2005-2010 I have investigated the gender differences in the processes of intracellular cholesterol
Veronika A. Myasoedova, MD, PhD
Personal Informations:
Education:
Research experience:
Positions:
Veronika A. Myasoedova
2
accumulation and the role of sex hormones in cellular and molecular mechanisms of
atherogenesis, and have work on research project of association of mitochondrial
mutations with atherosclerosis development and risk.
2011-2012 I have participated as a research assistant in the "Omega-3 fatty acids for prevention of
post-operative atrial fibrillation" clinical trial.
2011-2012 I have participate as coordinator in the clinical trial “Antiplatelet Effect of Low Doses of
Aspirin Taken Every 12 Hours in Patients Undergoing CABG and/or Aortic Valve
Surgery (ASABYVALV)”
2012-2014 I have participated as a local coordinator in “Steroids In caRdiac Surgery Trial” (SIRS).
2013-2015 I have participated as a coordinator in “Mitroflow Real Time Registry”
2014-2015 “Polyphemus: Administration of polyphenol rich supplement and early midterm
outcomes after cardiac surgery”.
2015-present I am coordinator in “Sorin Universal Registry on Aortic Valve Replacement”
2015-present I am coordinator in SILENT study “Study of cIrcuLating biomarkErs for the dentification
of patieNts subjected to aorTic valve degeneration”
2019-present I am research collaborator in "Genetic and epigenetic BDNF modification in frail
coronary artery disease patients with depression (DEPRECAD)" study
2004 – present Prof Alexander N Orekhov lexander N. Orekhov, PhD, DSc Head Laboratory of Angiopathology
Institute of General Pathology and Pathophysiology. Director Institute for Atherosclerosis
Research (Skolkovo) Moscow, Russia
2004 – present Dr. Igor Sobenin, MD, PhD, Russian Cardiology Research and Production Complex
2006 – present Prof Elena Tremoli PhD, Scietific Director of Centro Cardiologico Monzino IRCCS, Milan, Italy
2006 – present: Prof Damiano Baldassarre PhD, Professor at University of Milan, Department of
Pharmacological and Biomolecular Sciences, Milan, Italy.
2007 - 2014 Prof. Raimond Erbel, MD, Director, Department of Cardiology, West German Heart Centre
Essen, Division of Internal Medicine, University Essen Germany
2010 – present Prof Alessandro Parolari MD, PhD Associate Professor of Cardiac Surgery at University of
Milan, Responsible of Cardiacsurgery Unit – Translational Research Policlinico San Donato
IRCCS, Milan, Italy
2010 – present Prof. Francesco Alamanni, MD, PhD, Department of Clinical and Community Sciences
Department of Cardiovascular Diseases of the University of Milan, Head of Cardiac and
Vascular Surgery Unit, Centro Cardiologico Monzino ,IRCCS, Milan, Italy
2010 –present Dr Viviana Cavalca, Head Laboratory of metabolomics and cellular biochemistry of
atherotrombosis, Centro Cardiologico Monzino IRCCS, Milan, Italy
2010 – present Dr. J. Pablo Werba, MD, Head of the Unit for Atherosclerosis Prevention, Centro Cardiologico
Monzino, Milan, Italy
2013 – 2019 Dr. Dmitry Chistiakov PhD, Department of Neurochemistry, Division of Basic and Applied
Neurobiology, Serbsky Federal Medical Research Center of Psychiatry and Narcology, Moscow,
Russia
2013 – present Dr. Paolo Poggio, PhD, Head of Laboratory of Cardiac Biochemistry Aortic, Valvular and
Coronary Pathologies, Centro Cardiologico Monzino
Peer-review publications:
Scientific collaborations:
Veronika A. Myasoedova
3
1. Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus-
Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int J
Mol Sci. 2020 Mar 6;21(5):1835. doi: 10.3390/ijms21051835. PMID: 32155866 IF 4.183
2. Kirichenko TV, Myasoedova VA, Ravani AL, Sobenin IA, Orekhova VA, Romanenko EB, Poggio P, Wu
WK, Orekhov AN Carotid Atherosclerosis Progression in Postmenopausal Women Receiving a Mixed
Phytoestrogen Regimen: Plausible Parallels with Kronos Early Estrogen Replacement Study. Biology
(Basel). 2020 Mar 6;9(3):E48. doi: 10.3390/biology9030048. PMID: 32155747 IF N/A
3. Sobenin IA, Myasoedova VA, Iltchuk MI, Zhang DW, Orekhov AN. Therapeutic effects of garlic in
cardiovascular atherosclerotic disease. Chin J Nat Med. 2019 Oct;17(10):721-728. doi: 10.1016/S1875-
5364(19)30088-3. PMID: 31703752 IF 1.773
4. Poggio P, Cavallotti L, Myasoedova VA, Bonomi A, Songia P, Gripari P, Valerio V, Amato M, Barbieri S,
Faggiano P, Alamanni F, Veglia F, Pepi M, Tremoli E, Baldassarre D. Aortic Valve Sclerosis Adds to
Prediction of Short-Term Mortality in Patients with Documented Coronary Atherosclerosis. J Clin Med.
2019 Aug 5;8(8):1172. doi: 10.3390/jcm8081172. PMID: 31387275 IF 5.583
5. Di Minno MND, Poggio P, Conte E, Myasoedova V, Songia P, Mushtaq S, Cavallotti L, Moschetta D, Di
Minno A, Spadarella G, Pizzicato P, Pontone G, Pepi M, Andreini D. Cardiovascular Morbidity and
Mortality in Patients With Aortic Valve Calcification: A Systematic Review and Meta-Analysis. J
Cardiovasc Comput Tomogr. 2019 Jul-Aug;13(4):190-195. doi: 10.1016/j.jcct.2019.06.006. PMID:
31239172 IF 3.316
6. Porro B, Songia P, Myasoedova VA, Valerio V, Moschetta D, Gripari P, Fusini L, Cavallotti L, Canzano P,
Turnu L, Alamanni F, Camera M, Cavalca V, Poggio P. Endothelial Dysfunction in Patients with Severe
Mitral Regurgitation. J Clin Med. 2019 Jun 12;8(6):835. doi: 10.3390/jcm8060835. PMID: 31212807 IF
5.583
7. Poggio P, Songia P, Moschetta D, Valerio V, Myasoedova V, Perrucci GL, Pompilio G. MiRNA profiling
revealed enhanced susceptibility to oxidative stress of endothelial cells from bicuspid aortic valve. J Mol
Cell Cardiol. 2019 Apr 23. pii: S0022-2828(18)31066-6. doi: 10.1016/j.yjmcc.2019.04.024. PMID:
31026425 IF 5.296
8. Valerio V, Myasoedova VA, Moschetta D, Porro B, Perrucci GL, Cavalca V, Cavallotti L, Songia P,
Poggio P. Impact of Oxidative Stress and Protein S-Glutathionylation in Aortic Valve Sclerosis Patients
with Overt Atherosclerosis. J Clin Med. 2019 Apr 24;8(4). pii: E552. doi: 10.3390/jcm8040552. PMID:
31022838 IF 5.583
9. Myasoedova VA, Grechko AV, Zhang D, Orekhov AN. Inhibitors of DNA methylation and histone
deacetylation as epigenetically active drugs for anticancer therapy. Curr Pharm Des. 2019 Apr 5. doi:
10.2174/1381612825666190405144026. PMID: 30950345 IF 2.757
10. Glanz VY, Myasoedova VA, Grechko AV, Orekhov AN.Trans-sialidase associated with atherosclerosis :
defining the identity of a key enzyme involved in the pathology. Curr Drug Targets. 2019 Mar 7. [Epub
ahead of print] PMID: 30848200 IF 3.112
11. Summerhill V, Karagodin V, Grechko A, Myasoedova V, Orekhov A. Vasculoprotective Role of Olive Oil
Compounds via Modulation of Oxidative Stress in Atherosclerosis. Front Cardiovasc Med. 2018 Dec
21;5:188. doi: 10.3389/fcvm.2018.00188. eCollection 2018. Review. PMID: 30622950 IF N/A
12. Glanz VY, Myasoedova VA, Grechko AV, Orekhov AN. Sialidase activity in human pathologies. Eur J
Pharmacol. 2019 Jan 5;842:345-350. doi: 10.1016/j.ejphar.2018.11.014. Epub 2018 Nov 12. Review.
PMID: 30439363 IF 3.040
Veronika A. Myasoedova
4
13. Chistiakov DA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Role of androgens in
cardiovascular pathology. Vasc Health Risk Manag. 2018 Oct 15;14:283-290. doi:
10.2147/VHRM.S173259. eCollection 2018. Review. PMID: 30410343 IF N/A
14. Songia P, Chiesa M, Valerio V, Moschetta D, Myasoedova VA, D'Alessandra Y, Poggio P.Direct
screening of plasma circulating microRNAs. RNA Biol. 2018 Sep 25. doi:
10.1080/15476286.2018.1526538. PMID: 30252594 IF 5.216
15. Glanz VY, Myasoedova VA, Grechko AV, Orekhov AN. Inhibition of sialidase activity as a therapeutic
approach. Drug Des Devel Ther. 2018 Oct 10;12:3431-3437. doi: 10.2147/DDDT.S176220. PMID:
30349196 IF N/A
16. Karagodin VP, Sukhorukov VN, Myasoedova VA, Grechko AV, Orekhov AN. Diagnostics and Therapy of
human diseases - Focus on sialidases. Curr Pharm Des. 2018 Sep 10. doi:
10.2174/1381612824666180910125051. PMID: 30198428 IF 2.757
17. Kirichenko TV, Myasoedova VA, Shimonova TE, Melnichenko AA, Sviridov D, Sobenin IA, Mazus AI,
Orekhov AN, Bukrinsky MI. Atherosclerosis in subjects newly diagnosed with human immunodeficiency
virus infection. Biosci Rep. 2018 Jul 18;38(4). pii: BSR20180597. doi: 10.1042/BSR20180597. Print
2018 Aug 31. PMID: 29961673 IF 2.899
18. Myasoedova VA, Chistiakov DA, Grechko AV, Orekhov AN. Matrix metalloproteinases in pro-
atherosclerotic arterial remodeling. J Mol Cell Cardiol. 2018 Aug 30;123:159-167. doi:
10.1016/j.yjmcc.2018.08.026 PMID: 30172754 IF 5.296
19. Novel pharmacological targets for calcific aortic valve disease: Prevention and treatments. Myasoedova
VA, Ravani AL, Frigerio B, Valerio V, Moschetta D, Songia P, Poggio P.
Pharmacol Res. 2018 Aug 24;136:74-82. doi: 10.1016/j.phrs.2018.08.020. PMID: 30149054 IF 4.897
20. Zanobini M, Loardi C, Poggio P, Tamborini G, Veglia F, Di Minno A, Myasoedova V, Mammana LF, Biondi
R, Pepi M, Alamanni F, Saccocci M. The impact of pericardial approach and myocardial protection onto
postoperative right ventricle function reduction. J Cardiothorac Surg. 2018 Jun 5;13(1):55. doi:
10.1186/s13019-018-0726-5. PMID: 29866151 IF 1.117
21. Kirichenko TV, Myasoedova VA, Sobenin IA, Orekhov AN. Phytotherapy for prevention of
atherosclerosis-associated early cerebral ischemia. Curr Drug Metab. 2018 Mar 5. doi:
10.2174/1389200219666180305151601. PMID: 29512455 IF 2.659
22. Chistiakov DA, Melnichenko AA, Grechko AV, Myasoedova VA, Orekhov AN. Potential of anti-
inflammatory agents for treatment of atherosclerosis. Exp Mol Pathol. 2018 Jan 26. pii: S0014-
4800(17)30241-1. doi: 10.1016/j.yexmp.2018.01.008. [Epub ahead of print] Review. PMID: 29378168 IF
2.423
23. Chistiakov DA, Grechko AV, Myasoedova VA, Melnichenko AA, Orekhov AN. The role of monocytosis
and neutrophilia in atherosclerosis. J Cell Mol Med. 2018 Jan 24. doi: 10.1111/jcmm.13462. PMID:
29364567 IF 4.499
24. Chistiakov DA, Myasoedova VA, Grechko AV, Melnichenko AA, Orekhov AN. New biomarkers for
diagnosis and prognosis of localized prostate cancer. Semin Cancer Biol. 2018 Jan 19. doi:
10.1016/j.semcancer.2018.01.012..PMID: 29360504 IF 9.141
25. Chistiakov DA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Calcifying Matrix Vesicles
and Atherosclerosis. Biomed Res Int. 2017;2017:7463590. doi: 10.1155/2017/7463590. Epub 2017 Nov
7. Review. PMID: 2923872 IF 2.476
Veronika A. Myasoedova
5
26. Chistiakov DA, Myasoedova VA, Revin VV, Orekhov AN, Bobryshev YV. The impact of interferon-
regulatory factors to macrophage differentiation and polarization into M1 and M2. Immunobiology. 2018
Jan;223(1):101-111. doi: 10.1016/j.imbio.2017.10.005 PMID: 29032836 IF 2.720
27. Di Minno A, Zanobini M, Myasoedova VA, Valerio V, Songia P, Saccocci M, Di Minno MND, Tremoli E,
Poggio P. Could circulating fetuin A be a biomarker of aortic valve stenosis?
Int J Cardiol. 2017 Sep 17 PMID: 28931474
28. Chistiakov DA, Melnichenko AA, Myasoedova VA, Grechko AV, Orekhov AN. Role of lipids and
intraplaque hypoxia in the formation of neovascularization in atherosclerosis. Ann Med. 2017 Aug 11:1-
37. doi: 10.1080/07853890.2017.1366041.IF 3.715
29. Chistiakov DA, Melnichenko AA, Myasoedova VA, Grechko AV, Orekhov AN. Mechanisms of foam cell
formation in atherosclerosis. J Mol Med (Berl). 2017 Aug 7. doi: 10.1007/s00109-017-1575-8. IF 4.855
30. Zanobini M, Loardi C, Mammana FL, Kassem S, Alamanni F, DI Minno A, Poggio P, Myasaoedova V,
Saccocci M. Single-centre early experience with sutureless valve Perceval: focus onto size gaining. J
Cardiovasc Surg (Torino). 2017 Jul 24. doi: 10.23736/S0021-9509.17.10116-3. [Epub ahead of print] IF
2.179
31. Chistiakov DA, Melnichenko AA, Myasoedova VA, Grechko AV, Orekhov AN. Thrombospondins: A Role
in Cardiovascular Disease. Int J Mol Sci. 2017 Jul 17;18(7). pii: E1540. doi: 10.3390/ijms18071540.
Review. IF 3.226
32. Chistiakov DA, Grechko AV, Myasoedova VA, Melnichenko AA, Orekhov AN. Impact of the
cardiovascular system-associated adipose tissue on atherosclerotic pathology. Atherosclerosis. 2017
Jun 8. pii: S0021-9150(17)30267-8. doi: 10.1016/j.atherosclerosis.2017.06.017. [Epub ahead of print]
Review. IF 4.239
33. Kirichenko TV, Myasoedova VA, Orekhova VA, Ravani AL, Nikitina NA, Grechko AV, Sobenin IA,
Orekhov AN. Phytoestrogen-Rich Natural Preparation for Treatment of Climacteric Syndrome and
Atherosclerosis Prevention in Perimenopausal Women. Phytother Res. 2017 Jun 8. doi:
10.1002/ptr.5841. [Epub ahead of print] PMID: 28593720 IF 3.092
34. Ivanova EA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Small Dense Low-Density
Lipoprotein as Biomarker for Atherosclerotic Diseases. Oxid Med Cell Longev. 2017;2017:1273042. doi:
10.1155/2017/1273042. Epub 2017 May 7. Review. IF. 4.593
35. Parolari A, Cavallotti L, Andreini D, Myasoedova V, Banfi C, Camera M, Poggio P, Barili F, Pontone G,
Mussoni L, Centenaro C, Alamanni F, Tremoli E Coronary Bypass Grafting: Factors Related to Late
Events and Graft Patency (CAGE) study investigators. D-dimer is associated with arterial and venous
coronary artery bypass graft occlusion. J Thorac Cardiovasc Surg. 2017 Apr 27. IF 4.446
36. Chistiakov DA, Myasoedova VA, Orekhov AN, Bobryshev YV. Nanocarriers in improving chemotherapy
of multidrug resistant tumors: Key developments and perspective. Curr Pharm Des. 2017 Apr 7. doi:
10.2174/1381612823666170407123941. IF 2.611
37. Cavalca V, Rocca B, Veglia F, Petrucci G, Porro B, Myasoedova V, De Cristofaro R, Turnu L, Bonomi A,
Songia P, Cavallotti L, Zanobini M, Camera M, Alamanni F, Parolari A, Patrono C, Tremoli E. On-pump
Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of
Improved Dosing Regimens. Clin Pharmacol Ther. 2017 Apr 5. doi: 10.1002/cpt.702. [Epub ahead of
print] IF. 7.266
38. Paparella, D, Parolari, A, Rotunno, C, Vincent, J., Myasoedova, VGuida, P., De Palo, M., Margari, V,
Devereaux, P.J., Lamy, A., Alamanni, F, Yusuf, S., Whitlock, R The Effects of Steroids on Coagulation
Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy.
Seminars in Thoracic and Cardiovascular Surgery IF. N/A
Veronika A. Myasoedova
6
39. Songia P, Porro B, Chiesa M, Myasoedova V, Alamanni F, Tremoli E, Poggio P. Identification of Patients
Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. Oxid
Med Cell Longev. 2017;2017:6838921. doi: 10.1155/2017/6838921. Epub 2017 Feb 2. IF. 4.593
40. Chistiakov DA, Myasoedova VA, Revin VV, Orekhov AN, Bobryshev YV.The phenomenon of
atherosclerosis reversal and regression: Lessons from animal models. Exp Mol Pathol. 2017 Jan
17;102(1):138-145.IF. 2.423
41. Myasoedova VA, Ivashinnikova GA, Sobenin IA, Ivanova EA, Orekhov AN. Blood Serum Atherogenicity:
Cellular Test for the Development of Anti-Atherosclerotic Therapy. Curr Pharm Des. 2017 Jan 2. [Epub
ahead of print] PMID: 28042768 IF 2.611
42. Chistiakov DA, Killingsworth MC, Myasoedova VA, Orekhov AN, Bobryshev YV. CD68/macrosialin: not
just a histochemical marker. Lab Invest. 2017 Jan;97(1):4-13. doi: 10.1038/labinvest.2016.116. Epub
2016 Nov 21.. IF 4.857
43. Di Minno MN, Ambrosino P, Myasoedova VA, Amato M, Ventre I, Tremoli E, Di Minno A. Recombinant
activated factor VII (eptacog alfa activated, NovoSeven ® ) in patients with rare congenital bleeding
disorders. A systematic review on its use in surgical procedures. Curr Pharm Des. 2016 Dec 30. [Epub
ahead of print] PMID: 28034354 IF 2.611
44. Poggio P, Folesani G, Raffa GM, Songia P, Valenti V, Myasoedova V, Parolari A. Antihypertensive
Treatments In Patients Affected By Aortic Valve Stenosis. Curr Pharm Des. 2016 Nov 23. IF 2.611
45. Ivanova EA, Myasoedova VA, Melnichenko AA, Orekhov AN. Peroxisome proliferator-activated receptor
(PPAR) gamma agonists as therapeutic agents for cardiovascular disorders: Focus on atherosclerosis.
Curr Pharm Des. 2016 Nov 18. IF 2.611
46. Zakiev ER, Sobenin IA, Sukhorukov VN, Myasoedova VA, Ivanova EA, Orekhov AN. Carbohydrate
composition of circulating multiple-modified low-density lipoprotein. Vasc Health Risk Manag. 2016 Oct
14;12:379-385 IF N/A
47. Chistiakov DA, Myasoedova VA, Orekhov AN, Bobryshev YV. Epigenetically active drugs inhibiting DNA
methylation and histone deacetylation. Curr Pharm Des. 2016 Oct 21. [Epub ahead of print]. IF 2.611
48. Myasoedova VA, Kirichenko TV, Melnichenko AA, Orekhova VA, Ravani A, Poggio P, Sobenin IA,
Bobryshev YV, Orekhov AN. Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in
Postmenopausal Women. Int J Mol Sci. 2016 Aug 11;17(8). pii: E1318. doi: 10.3390/ijms17081318. IF
3.226
49. Songia P, Branchetti E, Parolari A, Myasoedova V, Ferrari G, Alamanni F, Tremoli E, Poggio P. Mitral
valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. J Mol Cell
Cardiol. 2016 Jun 20. pii: S0022-2828(16)30209-7. doi: 10.1016/j.yjmcc.2016.06.061. [Epub ahead of
print] IF. 5.680
50. Paparella D, Di Mauro M, Worms KB, Bolotin G, Russo C, Trunfio S, Scrofani R, Antona C, Actis Dato
G, Casabona R, Colli A, Gerosa G, Renzulli A, Serraino F, Scrascia G, Zaccaria S, De Bonis M,
Taramasso M, Delgado L, Tritto F, Marmo J, Parolari A, Myaseodova V, Villa E, Troise G, Nicolini F,
Gherli T, Whitlock R, Conte M, Barili F, Gelsomino S, Lorusso R, Sciatti E, Marinelli D, Di Giammarco G,
Calafiore AM, Sheikh A, Alfonso JJ, Glauber M, Miceli A; GIROC Investigators. Antiplatelet versus oral
anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair. J Thorac Cardiovasc Surg.
2016 Jan 5. pii: S0022-5223(15)02530-1. doi: 10.1016/j.jtcvs.2015.12.036. [Epub ahead of print] IF.
4.446
Veronika A. Myasoedova
7
51. Parolari A, Poggio P, Myasoedova V, Songia P, Bonalumi G, Pilozzi A, Pacini D, Alamanni F, Tremoli E.
Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction? Front
Cardiovasc Med. 2016 Jan 5;2:39 IF N/A
52. Sobenin IA, Myasoedova VA, Orekhov AN. Phytoestrogen-Rich Dietary Supplements in Anti-
Atherosclerotic Therapy in Postmenopausal Women. Curr Pharm Des. 2016;22(2):152-63. IF. 2.611
53. A Parolari, P Poggio, V Myasoedova, P Songia, A Pilozzi, F Alamanni, and E Tremoli. Molecular
pathways activation in coronary artery bypass surgery: which role for pump avoidance? J Cardiovasc
Med (Hagerstown). 2016 Jan;17(1):54-61. IF 1.510
54. Whitlock RP, Devereaux PJ, Teoh KH, Lamy A, Vincent J, Pogue J, Paparella D, Sessler DI,
Karthikeyan G, Villar JC, Zuo Y, Avezum Á, Quantz M, Tagarakis GI, Shah PJ, Abbasi SH, Zheng H,
Pettit S, Chrolavicius S, Yusuf S; SIRS Investigators. Methylprednisolone in patients undergoing
cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet. 2015 Sep
26;386(10000):1243-53. IF. 45.213
55. Ivanova EA, Parolari A, Myasoedova V, Melnichenko AA, Bobryshev YV, Orekhov AN. Peroxisome
proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery. J
Cardiol. 2015 Jun 10. IF.2.782
56. Masson S, Wu JH, Simon C, Barlera S, Marchioli R, Mariani J, Macchia A, Lombardi F, Vago T, Aleksova
A, Dreas L, Favaloro RR, Hershson AR, Puskas JD, Dozza L, Silletta MG, Tognoni G, Mozaffarian D,
Latini R; OPERA Investigators. Circulating cardiac biomarkers and postoperative atrial fibrillation in the
OPERA trial. Eur J Clin Invest. 2015 Feb;45(2):170-8. doi: 10.1111/eci.12393. Epub 2015 Jan 7 IF 2.834
57. Werba JP, Misaka S, Giroli MG, Yamada S, Cavalca V, Kawabe K, Squellerio I, Laguzzi F, Onoue S,
Veglia F, Myasoedova V, Takeuchi K, Adachi E, Inui N, Tremoli E, Watanabe H1. Overview of green tea
interaction with cardiovascular drugs. Curr Pharm Des. 2015;21(9):1213-9. IF 3.31
58. Parolari A, Songia P, Myasoedova V, Poggio P. Re: Development of a next-generation tissue valve
using a glutaraldehyde-fixed porcine aortic valve treated with decellularization, alpha-galactosidase,
space filler, organic solvent and detoxification. Eur J Cardiothorac Surg. 2015 Jul;48(1):114. IF 3.04
59. Sobenin IA, Myasoedova VA, Anisimova EV, Pavlova XN, Möhlenkamp S, Schmermund A, Seibel R,
Berenbein S, Lehmann N, Moebus S, Karl-Heinz J, Orekhov AN, Erbel R. Blood Serum Atherogenicity
and Coronary Artery Calcification. Curr Pharm Des. 2014 Feb 12 PMID: 24533940 IF 3.311
60. Cavalca V, Tremoli E, Porro B, Veglia F, Myasoedova V, Squellerio I, Manzone D, Zanobini M, Trezzi M,
Di Minno MN, Werba JP, Tedesco C, Alamanni F, Parolari A. “Oxidative stress and nitric oxide pathway
in adult patients who are candidates for cardiac surgery: patterns and differences” Interact Cardiovasc
Thorac Surg. 2013 Dec;17(6):923-30. doi: 10.1093/icvts/ivt386. Epub 2013 Sep 7. PMID: 24014619 IF
3.526
61. Mozaffarian D, Marchioli R, Macchia A, Silletta MG, Ferrazzi P, Gardner TJ, Latini R, Libby P, Lombardi
F, O'Gara PT, Page RL, Tavazzi L, Tognoni G; OPERA Investigators. Fish oil and postoperative atrial
fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA)
randomized trial. JAMA. 2012 Nov 21;308(19):2001-11. IF 29.98
62. Sobenin IA, Sazonova MA, Ivanova MM, Zhelankin AV, Myasoedova VA, Postnov AY, Nurbaev SD,
Bobryshev YV, Orekhov AN “Mutation C3256T of mitochondrial genome in white blood cells: novel
genetic marker of atherosclerosis and coronary heart disease” PLoS One. 2012;7(10):e46573. doi:
10.1371/journal.pone.0046573. Epub 2012 Oct 2. PMID: 23056349 IF 3.730
63. Orekhov AN, Sobenin IA, Korneev NV, Kirichenko TV, Myasoedova VA, Melnichenko AA, Balcells M,
Edelman ER, Bobryshev YV. Anti-Atherosclerotic Therapy Based on Botanicals. Recent Pat Cardiovasc
Drug Discov. 2013 Apr;8(1):56-66PMID: 23176379 IF 0
Veronika A. Myasoedova
8
64. Miasoedova VA, Kirichenko TV, Orekhova VA, Sobenin IA, Mukhamedova NM, Martirosian DM,
Karagodin VP, Orekhov AN.[Study of intima-medial thickness (IMT) of the carotid arteries as an indicator
of natural atherosclerosis progress in Moscow population]. Patol Fiziol Eksp Ter. 2012 Jul-Sep;(3):104-8.
Russian IF 0
65. Melnichenko AA, Aksenov DV, Myasoedova VA, Panasenko OM, Yaroslavov AA, Sobenin IA, Bobryshev
YV, Orekhov AN. Pluronic Block Copolymers Inhibit Low Density Lipoprotein Self-Association. Lipids.
2012 Oct;47(10):995-1000. Epub 2012 Jul 14PMID: 22797973 IF 2.557
66. Parolari A, Pesce LL, Pacini D, Mazzanti V, Salis S, Sciacovelli C, Rossi F, Alamanni F; Monzino
Research Group on Cardiac Surgery Outcomes. Risk factors for perioperative acute kidney injury after
adult cardiac surgery: role of perioperative management. Ann Thorac Surg. 2012 Feb;93(2):584-91. IF
3.664
67. Orekhov AN, Sobenin IA, Orekhova VA, Mel'nichenko AA, Miasoedova VA, Mukhamedova NM,
Martirosian DM, Pshezhetskiĭ AV, Karagodin VP. Cultured cell systems for revelation of new drugs
antiatherosclerotic effects and their mechanisms investigation. Patol Fiziol Eksp Ter. 2012 Jan-
Mar;(1):33-9. Russian. IF N/A
68. Bobryshev IuV, Karagodin VP, Kovalevskaia ZhI, Miasoedova VA, Shapyrina EV, Saliamov VI,
Kargapolova IuM, Galaktionova DIu, Mel'nichenko AA, Orekhov AN. Numbers of cells and cell
proliferation in intima of different human arteries. Tsitologiia. 2011;53(10):815-25. Russian. IF N/A
69. Sobenin IA, Surnin SA, Karagodin VP, Miasoedova VA, Kirichenko TV, Chuprakova OV, Kozhevnikova
IuA, Kovalevskaia LO, Orekhov AN. Variability of intima-media thickness of the common carotid arteries
in Moscow city population without clinical symptoms of atherosclerosis. Ter Arkh. 2011;83(12):58-62. IF
0.88I
70. Nikitina NA, Sobenin IA, Myasoedova VA, Korennaya VV, Mel'nichenko AA, Khalilov EM, Orekhov AN.
Antiatherogenic effect of grape flavonoids in an ex vivo model. Bull Exp Biol Med. 2006 Jun;141(6):712-
5 IF 0.34
1. XXVIII National Congress of the Italian Society for Cardiac Surgery 2016
Biomarkers in Acute Aortic Syndrome: good or bad news?
November 26 th , 2016 Rome, Italy.
1. Joint Meeting of the ESC Working Groups on Myocardial Function and Cellular Biology of the Heart, 9-
11 May, 2019, Naples, Italy
Vincenza Valerio, Paola Songia, Donato Moschetta, Laura Cavallotti, Veronika Myasoedova, Paolo Poggio.
Protein glutathionylation promotes calcification via oxidative DNA damage in human valve endothelial cells.
2. 86th Congress of the European Atherosclerosis Society, 26-29 May,2019, Maastricht, The Netherlands
V. A. Myasoedova, M. Rondinelli, L. Cavallotti, M. Naliato, P. Songia, V. Valerio, D. Moschetta, F. Alamanni,
M.Pepi, S. Genovese, and P. Poggio. Gender difference and aortic valve sclerosis in coronary artery
disease patients.
3. American Diabetes Association, 79 Scientific Sessions, 7-11 June 2019, San Francisco, USA
V Myasoedova, S Genovese, L Cavallotti, A Bonomi, P Gripari, J Campodonico, V Valerio, M Rondinelli, P
Songia, M Pepi, F Alamanni and P Poggio. Aortic Valve Sclerosis and Diabetes Mellitus are Independent
Predictors of All-Cause Mortality in a Large Surgical Myocardial Revascularization Cohort.
Invited Lectures:
Congress Communications:
Veronika A. Myasoedova
9
4. ESC congress 2018, Monaco, Germany August 24 – 28,
Chiesa, V. Myasoedova, P. Gripari, V. Valerio, S. Montanari, D. Moschetta, M. Pepi, G. I. Colombo, D.
Baldassarre, P. Poggio. Patients with aortic valve sclerosis show a different circulating miRNA profile
compared to healthy subjects.
5. 86th Congress of the European Atherosclerosis Society, 2018
V. Myasoedova, B. Porro, V. Valerio, S. Montanari, P. Songia, D. Moschetta, P. Gripari, L. Fusini, M. Pepi,
V. Cavalca, P. Poggio. Aortic valve sclerosis is associated with systemic oxidative stress in patients
undergoing surgical myocardial revascularization.
6. Vascular Discovery: From Genes to Medicine – Scientific Sessions 2018
V Valerio, S Montanari, P Songia, B Porro, D Moschetta, L Cavallotti, V Myasoedova and P Poggio
Protein glutathionylation promotes calcification via oxidative DNA damage in human valve endothelial cells.
May 10 – 12, San Francisco, CA, USA.
7. Frontiers in CardioVascular Biology 2018
P Songia, V Myasoedova, P Gripari, V Valerio, L Fusini, L Cavallotti, G Tamborini, M Pepi and P Poggio
New signaling pathways potentially involved in human mitral valve prolapse.April 20 – 22, 2018 Vienna,
Austria.
8. Frontiers in CardioVascular Biology 2016
P Songia, V Myasoedova, F Alamanni, E Tremoli and P Poggio Statin paradox in association with
calcification of bicuspid aortic valve interstitial cells. July 8 – 10, 2016 Florence, Italy.
9. European Society of Cardiology 2015
P Poggio, P Songia, V Myasoyedova, A Parolari, F Alamanni and E Tremoli. Mitral valve prolapse: crosstalk
between human valve endothelial and interstitial cells. August 29 – September 2, 2015 London, United
Kingdom.
10. AATS Mitral Conclave 2015
P Songia, V Myasoedova, F Alamanni, A Parolari, E Tremoli and P Poggio. Osteoprotegerin: a New
Biomarker For Mitral Valve Prolapse? April 23 – 24, 2015 New York, NY, USA.
11. 83 rd Congress of the European Atherosclerosis Society, 2015
IA Sobenin, VA Myasoedova, AN Orekhov, R Erbel. Between-population variability of common carotid
intima-media thickness in industrially developed regions in Germany and Russia. Atherosclerosis 241 (1),
e164 2015 22-25 March, 2015,Glasgow, Scotland
12. XXVII National Congress of the Italian Society for Cardiac Surgery 2014
P Poggio, P Songia, V Myasoedova, F Veglia, E Tremoli, F Alamanni and A Parolari Osteoprotegerin is
expressed at high concentration in patients with mitral valve prolapse. November 28 – 30, 2014 Rome, Italy.
13. American Heart Association (AHA) 2014
Alessandro Parolari, Laura Cavallotti, Veronika Myasoedova, Cristina Banfi, Marina Camera, Daniele
Andreini, Francesco Alamanni, Elena Tremoli. Preoperative D-dimer and haptoglobyn phenotype predict
both venous and arterial grafts occlusion at mid-term follow-up. Results from the CoronAry Bypass Grafting:
factors related to late events and Graft patEncy (CAGE) study. Circulation 130 (Suppl 2), A13814-A13814
2014, November 15 - 19, 2014; Chicago, Illinois
14. 82 nd Congress of the European Atherosclerosis Society, 2014
I. Sobenin, V. Orekhova, Y. Bobryshev, A. Orekhov, V. Myasoedova, A. Ravani, E. Tremoli, D. Baldassarre.
The comparative study of common carotid intima-media thickness in Russian and Italian high-risk
individuals. Atherosclerosis 235 (2), e233 2014. Madrid, Spain, from 31 May - 3 June, 2014.
15. 79 th Congress of the European Atherosclerosis Society, 2011
Veronika A. Myasoedova
10
VA Myasoedova, IA Sobenin, DM Merculova, TV Kirichenko, UA Merculov Gender differences in the
development of subclinical atherosclerosis in patients with early signs of cerebrovascular insufficiency
Atherosclerosis, Supplements 12 (1), 155-155 2011, June 26 - 29, 2011; Gothenburg, Sweden.
16. 78 th Congress of the European Atherosclerosis Society, 2010
Orekhov A, Andreeva E, Andrianova I, Kzhyshkowska J, Gratchev A. Cell proliferation in different
atherosclerotic lesions of human arteries. 78th Congress of European Atherosclerosis Society, Hamburg,
Germany, June 20-23, 2010. Atherosclerosis Suppl. 2010, 11(2):137. June 20 - 23, 2010; Hamburg,
Germany
17. 78 th Congress of the European Atherosclerosis Society, 2010
Sobenin I, Myasoedova V, Kirichenko T, Chuprakova O, Bauer M, Erbel R, Orekhov A. The comparative
study of common carotid intima-media thickness in Russian and German populations. 78th Congress of
European Atherosclerosis Society, Hamburg, Germany, June 20-23, 2010. Atherosclerosis Suppl. 2010,
11(2):181.
18. 78 th Congress of the European Atherosclerosis Society, 2010
Orekhova E, Myasoedova V, Sobenin I, Orekhov A. Seasonal differences in trans-sialidases activity. 78th
Congress of European Atherosclerosis Society, Hamburg, Germany, June 20-23, 2010. Atherosclerosis
Suppl. 2010, 11(2):130.
19. 78 th Congress of the European Atherosclerosis Society, 2010
Sobenin I, Myasoedova V, Kirichenko T, Anisimova E, Castelnuovo S, Amato M, Frigerio B, Ravani A,
Orekhov A, Tremoli E, Baldassarre D, on behalf of the IMPROVE Study Group. Common carotid intima-
media thickness in high-risk patients in Russia and European populations. 78th Congress of European
Atherosclerosis Society, Hamburg, Germany, June 20-23, 2010. Atherosclerosis Suppl. 2010, 11(2):55.
20. Arteriosclerosis, Thrombosis and Vascular Biology 2010
Orekhova EA, Myasoedova VA, Sobenin IA, Orekhov AN. Changes in trans-sialidase activity in the course
of the year. Arteriosclerosis, Thrombosis and Vascular Biology 2010 Scientific Sessions, April 8-10. 2010,
Abstracts. p. 29
21. Arteriosclerosis, Thrombosis and Vascular Biology 2010
Orekhov AN, Myasoedova VA. Reduction of intracellular cholesterol accumulation caused by sex
hormones. Arteriosclerosis, Thrombosis and Vascular Biology 2010 Scientific Sessions, April 8-10. 2010,
Abstracts. p. 57
22. Arteriosclerosis, Thrombosis and Vascular Biology 2008
Andrianova IV, Myasoedova VA, Orekhova EA, Orekhov AN. The thickness of proteoglycan-rich arterial
sublayer is increased in men: A morphological background for the development of diffuse intimal thickening.
Arteriosclerosis, Thrombosis and Vascular Biology 2008 Scientific Sessions, April 16-18. 2008, Abstracts. p.
62
23. XVI International Symposium on Drugs Affecting Lipid Metabolism, 2007
Sobenin IA, Myasoedova VA, Orekhov AN. Antiatherogenic action of isoflavonoid-rich botanicals: an
implementation for atherosclerosis prevention in postmenopausal women. XVI International Symposium on
Drugs Affecting Lipid Metabolism, New York, USA, October 4-7, 2007. J Clin Lipidol 2007, 1(5):491.
24. XVI International Symposium on Drugs Affecting Lipid Metabolism, 2007
Sobenin IA, Myasoedova VA, Orekhov AN. Human blood serum-induced intracellular cholesterol
accumulation: the relationship to atherosclerosis development. XVI International Symposium on Drugs
Affecting Lipid Metabolism, New York, USA, October 4-7, 2007. J Clin Lipidol 2007, 1(5):491.
25. XIV International Symposium on Atherosclerosis, 2006
Gorchakova TV, Myasoedova VA, Sobenin IA, Orekhov AN. The reduction of serum atherogenicity by
natural anti-inflammatory drug. XIV International Symposium on Atherosclerosis, Rome, Italy, June 18-22,
2006. Atherosclerosis 2006 7(3):230-231.
Veronika A. Myasoedova
11
26. XIV International Symposium on Atherosclerosis, 2006
Korennaya VV, Myasoedova VA, Nikitina NA, Sobenin IA, Orekhov AN. Bioflavonoid-rich botanicals reduce
blood serum atherogenicity in perimenopausal women. XIV International Symposium on Atherosclerosis,
Rome, Italy, June 18-22, 2006. Atherosclerosis 2006 7(3):444.
27. 75 th Congress of the European Atherosclerosis Society, 2005
Nikitina N, Korennaya V, Myasoedova V, Khalilov E, Sobenin I, Orekhov A. Antiatherogenic effects of
phytoestrogens in postmenopausal women. 75th Congress of the European Atherosclerosis Society,
Prague, Czech Republic, April 23-26, 2005. Atherosclerosis 2005 6(1):115-116.
28. 75 th Congress of the European Atherosclerosis Society, 2005
Sobenin I, Myasoedova V, Orekhov A. Antiatherogenic potency of phytoestrogen-rich plants: the viewpoint
for clinical implications. 75th Congress of the European Atherosclerosis Society, Prague, Czech Republic,
April 23-26, 2005. Atherosclerosis 2005 6(1):121-122.
29. XIIIth International Symposium on Atherosclerosis, 2003
Sobenin IA, Nikitina NA, Myasoedova VA, Korennaya VV, Khalilov EG, Orekhov AN. Antiatherogenic
properties of isoflavones from phytoestrogen-rich botanicals. XIIIth International Symposium on
Atherosclerosis, Kyoto, Japan, September 28 – October 2, 2003. Atherosclerosis Supplements 2003
4(2):339.
- Russian: Mother language
- Italian: Fluent
- English: Fluent
- German: Basic
- Finalist of Young Investigator Award, 13th Russian National Congress «Human and Drug», 2006
- Post-Doctoral Fellowship year 2011 – Fondazione Umberto Veronesi
2010: Certificate in “Specialized training programme on technology commercialization”, INNOVA S.p.A
Tiburtino Technology Park, Roma Italy
2007: Certificate in Carotid Ultrasound Imaging, Cardiology Monzino Centre, Milan, Italy
2006: Certificate in Carotid Ultrasound Imaging, University of Kuopio, Kuopio, Finland
Guest Editor Activities:
1. Pharmaceutical and Nutraceutical Strategies for Prevention and Therapy of Cardiovascular, Aging, and
Metabolic Diseases. BioMed Research International
2. Cellular and Molecular Disorders as the Basis for Atherosclerosis and Related Diseases. Oxidative
Medicine and Cellular Longevity.
3. Individualized Conventional, Complementary, and Alternative Treatment in Cardiovascular Diseases.
Evidence-Based Complementary and Alternative Medicine.
Editorial Board Member in a peer-reviewed Open Access online journal Vessel Plus. ISSN 2574-1209
Awards:
Editorial Positions:
Languages:
Courses:
Veronika A. Myasoedova
12
ORCID orcid.org/0000-0001-8414-5300; ResearcherID:K-1024-2016; Scopus Author ID: 56248042600
H-Index according to Scopus: 14